Prognostic factors in severe eosinophilic asthma in children

被引：0
|
作者：
Martinez Rivera, Carlos [1 ]
Padro Casas, Clara [2 ]
Basagana Torrento, Maria [2 ]
Rivera Ortun, Marisa [1 ]
Pollan Guisasola, Carlos [3 ]
Navarro Ferrando, Jose Tomas [4 ]
Martinez Caceres, Eva [5 ]
Teniente Serra, Aina [5 ]
Francoso Vicente, Alicia [1 ]
Martinez Colls, Maria Del Mar [6 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Dept Resp Med, Badalona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Dept Allergy, Badalona, Spain
[3] Hosp Badalona Germans Trias & Pujol, Dept Otorhinolaryngol, Badalona, Spain
[4] Hosp Badalona Germans Trias & Pujol, Dept Hematol, Badalona, Spain
[5] Hosp Badalona Germans Trias & Pujol, Dept Immunol, Badalona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Dept Pediat, Pediat Pulmonol Unit, Badalona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA1290
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1290
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for Omalizumab: a single centre experience
    Lim, Yu Ting
    Williams, Thomas
    Langley, Ross
    Weir, Elise
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype
    Gupta, Atul
    Ikeda, Masanori
    Geng, Bob
    Azmi, Jay
    Price, Robert G.
    Bradford, Eric S.
    Yancey, Steven W.
    Steinfeld, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (05) : 1336 - +
  • [43] Clinical usefulness of mepolizumab in severe eosinophilic asthma
    Menzella, Francesco
    Lusuardi, Mirco
    Montanari, Gloria
    Galeone, Carla
    Facciolongo, Nicola
    Zucchi, Luigi
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 907 - 916
  • [44] Biological treatment is approved for severe eosinophilic asthma
    Mayor, Susan
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355 : i6472
  • [45] Refractory eosinophilic airway inflammation in severe asthma
    Payne, DNR
    Bush, A
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (12) : 1385 - 1385
  • [46] First therapy option for severe eosinophilic asthma
    Einecke D.
    MMW - Fortschritte der Medizin, 2016, 158 (7) : 70 - 70
  • [47] Efficacy of Benralizumab in patients with severe eosinophilic asthma
    Soto Hurtado, E.
    Rodriguez Gallego, Y.
    Arzola Rodriguez, M.
    PNEUMOLOGIE, 2023, 77 : S25 - S26
  • [48] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
  • [49] Bronchodilator response for oscillometry in severe eosinophilic asthma
    Chan, R.
    Kuo, C. R. W.
    Lipworth, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] DUAL BIOLOGIC USE IN SEVERE EOSINOPHILIC ASTHMA
    Patrawala, S.
    Thayer, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S143 - S143
12345